✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals

Epigral Ltd.

EPIGRAL

Market Cap
₹8,256 Cr.
P/E
23.72

Epigral Ltd.

  • Epigral
  • DCM Shriram
  • Guj. Alkalies & Chem
FAQs on Epigral Ltd. Shareprice

Epigral has given better returns compared to its competitors.
Epigral has grown at ~18.27% over the last 3yrs while peers have grown at a median rate of -2.47%

Yes, Epigral is expensive.
Latest PE of Epigral is 23.43, while 3 year average PE is 22.95.
Also latest EV/EBITDA of Epigral is 13.06 while 3yr average is 10.98.

View FAQ's On Business
Growth Table
  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem
Balance Sheet
  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem
Cash Flow
  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem
Quarterly Results
  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Epigral Ltd. Financials

Balance sheet of Epigral is strong.
But short term working capital might become an issue for this company.

The debt of Epigral is decreasing.
Latest debt of Epigral is ₹889 Crs as of Sep-24.
This is less than Mar-24 when it was ₹949 Crs.

The profit is oscillating.
The profit of Epigral is ₹347 Crs for TTM, ₹196 Crs for Mar 2024 and ₹353 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Epigral latest dividend payout ratio is 10.61% and 3yr average dividend payout ratio is 8.24%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech